Cellcept and Ranexa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Ranexa (ranolazine). Common drug interactions include malaise among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Ranexa. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Ranexa?

Ranexa has active ingredients of ranolazine. It is often used in angina. eHealthMe is studying from 11,758 Ranexa users. Check the latest studies of Ranexa.

On Aug, 09, 2026

36 people who take Cellcept and Ranexa together, and have interactions are studied.

What are the common drug interactions of Cellcept and Ranexa, by gender? *:

female:

Malaise (a feeling of general discomfort or uneasiness)
Hospitalisation
Pneumonia
Sepsis (a severe blood infection that can lead to organ failure and death)
Abdominal pain upper
Crest syndrome (thick, dry and fibrous skin)
Death
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Dyspnoea (difficult or laboured respiration)

male:

Pain
Arthralgia (joint pain)
Gait disturbance
Headache (pain in head)
Hypoaesthesia (reduced sense of touch or sensation)
Hypokinesia (decreased bodily movement)
Sedation
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
Nerve injury

What are the common drug interactions of Cellcept and Ranexa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cardiac disorder
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

40-49:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Dyspepsia (indigestion)
Dyspnoea (difficult or laboured respiration)

50-59:

Pneumonia
Sepsis (a severe blood infection that can lead to organ failure and death)
Blood glucose increased
Crest syndrome (thick, dry and fibrous skin)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Malaise (a feeling of general discomfort or uneasiness)

60+:

Arthralgia (joint pain)
Balance disorder
Hypoaesthesia (reduced sense of touch or sensation)
Hypokinesia (decreased bodily movement)
Pain
Sedation
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
Nerve injury
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)

What are the existing conditions these people have? *

Post Laminectomy Syndrome: 8 people, 22.22%
Neuralgia (pain in one or more nerves): 8 people, 22.22%
Spinal Osteoarthritis (joint cartilage loss in spine): 6 people, 16.67%
Cardiac Failure Congestive: 6 people, 16.67%
Psoriasis (immune-mediated disease that affects the skin): 5 people, 13.89%
Nuclear Magnetic Resonance Imaging Abdominal: 4 people, 11.11%
Chronic Renal Failure (kidney failure): 4 people, 11.11%
Renal Artery Stenosis (narrowing of renal artery): 4 people, 11.11%
Nuclear Magnetic Resonance Imaging Brain: 4 people, 11.11%
Stable Angina (a constant chest pain): 4 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Ranexa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously